Restart Life Sciences Corp. (CSE:HEAL)
Canada · Delayed Price · Currency is CAD 0.1100
0.00 (0.00%)
Feb 6, 2026, 3:30 PM EST
Restart Life Sciences Market Cap
Restart Life Sciences has a market cap or net worth of CAD 5.94 million as of February 10, 2026. Its market cap has increased by 166.81% in one year.
Market Cap
5.94M
Enterprise Value
5.80M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.11
Market Cap Chart
Since September 22, 2006, Restart Life Sciences's market cap has increased from 4.41M to 5.94M, an increase of 34.75%. That is a compound annual growth rate of 1.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 5.94M | -10.27% |
| Dec 31, 2025 | 6.62M | 512.13% |
| Dec 31, 2024 | 1.08M | -63.28% |
| Dec 29, 2023 | 2.94M | -79.49% |
| Dec 30, 2022 | 14.35M | 134.03% |
| Dec 31, 2021 | 6.13M | -74.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| COSCIENS Biopharma | 8.72M |
| Marvel Biosciences | 8.70M |
| Kane Biotech | 7.26M |
| BioVaxys Technology | 7.06M |
| PharmaTher Holdings | 6.83M |
| Quest PharmaTech | 6.77M |
| Aptose Biosciences | 5.77M |
| MYND Life Sciences | 5.22M |